Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy for PD-(L)1 Resistant NSCLC Showcased in Oral Presentation at 2024 Asian Conference on Lung Cancer HONG KONG, Dec. 4, 2024 /PRNewswire/ — Akeso, Inc. (9926.HK) ("Akeso" or… CISION PRNewswireDecember 4, 2024
Press ReleaseSeeing Machines releases the 2023-24 Guardian Insights Report, highlighting alarming trends in driver fatigue and distraction from around the world Over 11.6 million risky driving events recorded across 3.6 billion kilometres of… CISION PRNewswireDecember 4, 2024
Press ReleaseInterlace Secures $10 Million in Series B1 Funding, Expands Leadership Team to Accelerate Global Growth SINGAPORE, Dec. 4, 2024 /PRNewswire/ — Interlace, a global card issuance and… CISION PRNewswireDecember 4, 2024
Press ReleaseSANY at bauma CHINA 2024: Pioneering New Quality Development SHANGHAI, Dec. 4, 2024 /PRNewswire/ — bauma CHINA 2024 is in full… CISION PRNewswireDecember 4, 2024
Global Times interview with Maria João Rodrigues on China-Europe relations BEIJING, Dec. 4, 2024 /PRNewswire/ — The 2024 Understanding China Conference is… CISION PRNewswireDecember 4, 2024
Press ReleaseBybit Celebrates Six Years of Transformational Growth DUBAI, UAE, Dec. 4, 2024 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency… CISION PRNewswireDecember 4, 2024
Press ReleaseMUWA NISEKO Collaborates with Ginori 1735 to Celebrate the Year of the Snake in Style "New Year Red Bliss" Promises a Luxury Stay with Limited Italian Porcelain… CISION PRNewswireDecember 4, 2024
Press ReleaseeCloudvalley Awarded a 2024 AWS Partner Award eCloudvalley recognized as MSP Partner of the Year winner, one of many… CISION PRNewswireDecember 4, 2024
